Article
BRAF and RAS mutations in Vietnamese patients with ameloblastoma.
BMC oral health - 13 Apr 2026
Hoang Kien Ai, Nguyen Chi Thi Kim, Ho Chuong Quoc, Duong Tram Bich, Luu Thao Thi Thu, Bui Tam Thi Thanh, Huynh Nam Cong Nhat, Vu Hoang Anh, Vo Tuyen Dac
Abstract excerpt
BACKGROUND: Ameloblastoma is a benign but locally aggressive odontogenic tumor. Genetic mutations in the mitogen-activated protein kinase (MAPK) signaling pathway, particularly those in BRAF and RAS, have been increasingly implicated in its pathogenesis, but remain underreported in Vietnamese patients. METHODS: Ninety-six formalin-fixed paraffin-embedded (FFPE) ameloblastoma samples from Vietnamese patients were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.